wr 1065 has been researched along with Cancer of Pancreas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WK; Dantzer, R; de la Cruz Bonilla, M; Deorukhkar, A; Fujimoto, TN; Garcia, CJG; Grossberg, AJ; Horvath, TD; Lin, D; Lorenzi, PL; Mason, KA; Molkentine, JM; Piwnica-Worms, H; Samuel, ELG; Taniguchi, CM; Tour, JM | 1 |
1 other study(ies) available for wr 1065 and Cancer of Pancreas
| Article | Year |
|---|---|
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Topics: Administration, Oral; Amifostine; Animals; Female; Intestine, Small; Male; Mercaptoethylamines; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Radiation Dosage; Radiation Protection; Radiation-Protective Agents | 2019 |